In the current study, we explored whether proliferative effects of angiotensin on CRC cells can be suppressed by Losartan by investigating downstream targets of Angiotensin/AT1R signaling, such as PI3K/AKT/ mTOR pathway activity and cyclin D1 expression. Here, AKT1 is linked to colorectal carcinoma.